20.06.2013 07:20 Uhr, Quelle: Wallstreet online

Algeta celebrates the official opening of its commercial production facility for Xofigo® (radium Ra 223 dichloride) at the Institute for Energy Technology (IFE) in Norway

Not intended for US media Oslo, Norway, 20 June 2013 - Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, today celebrates the official opening of its commercial production facility for Xofigo® …

Weiterlesen bei Wallstreet online